Login / Signup

Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait.

Ali Hadi AbdullahAnke-Peggy HoltorfMaryam Al-HussainiJacinthe LemayMaryam AlowayeshZoltán Kaló
Published in: Journal of pharmaceutical policy and practice (2019)
A MCDA model was successfully adapted to the Kuwait decision context by a group of Kuwaiti pharmacists from a broad range of institutions. The participants agreed with the approach and considered it suitable to improve the transparency and consistency of decision making for off-patent pharmaceuticals in Kuwait. A pilot implementation project was proposed.
Keyphrases
  • decision making
  • quality improvement
  • primary care
  • healthcare
  • study protocol
  • randomized controlled trial
  • clinical trial